http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080006004-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d269c8e41f178194d858c230c9f85e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
filingDate 2006-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df16dc246d689398e58eee75068aae5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fa41410fc1445409c0ee0a38f074737
publicationDate 2008-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20080006004-A
titleOfInvention 2-amido-6-amino-8-oxopurine derivative, a toll-like receptor modulator for the treatment of viral infections such as cancer and hepatitis C
abstract The present invention relates to purine derivatives, methods for their preparation, compositions containing them and their use. The present invention provides compounds of formula (I)n n n <Formula I>n n n n n n n n Wherein R 1 , R 2 , R 3 , R 9 , R 9a and Y are as defined in the specification. More specifically, the present invention relates to the use of purine derivatives in the treatment of various viral infections and immune or inflammatory disorders, including the regulation of toll-like receptors (TLRs), in particular disorders associated with agonism. Accordingly, the compounds of the present invention are useful for the treatment of infectious diseases such as hepatitis (eg HCV, HBV), genetically related viral infections, inflammatory diseases such as asthma and arthritis, and cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101482999-B1
priorityDate 2005-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466966374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468021144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466966373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466990816

Total number of triples: 37.